INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/27/2026
Back to search
Official data from USPTO
ID-NET ABC 123
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
02/28/2026
Trademark type
Combined
Nice classes
9, 42
Filing date
05/09/2017
Registration date
12/11/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2025
Last transaction
02/28/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
BE
Examiner
TAYLOR, DAVID T
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ID-NET" in the color black. To the left of the wording is a design consisting of three blocks resembling dice or toy building blocks in the colors red, white and shades of blue. The design and wording are separated by a blue vertical line.
Holders and representatives
Holders
INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer software for data management and statistics in the field of clinical trials for pharmaceuticalspharmaceutical drug development and pharmaceutical product evaluation; calculating machinesdata processing equipmentcomputers; software in connection with the management of clinical trials for pharmaceutical products
Class 42
Scientific and technological servicesdesignplanning and conducting of clinical trials and analysis of clinical data in the field of clinical trials for pharmaceuticalspharmaceutical drug development and pharmaceutical product evaluation; design and development of computer hardware and software relating to the management of clinical trials for pharmaceuticals; rental of software relating to the management of clinical trials for pharmaceuticals; rental of software in connection with the management of clinical trials for pharmaceutical products
Publications
History of USPTO decisions and trademark events.
41 publications found
C71T
CANCELLED SECTION 71
06/27/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/10/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/19/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
03/19/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2018
PUBO
PUBLISHED FOR OPPOSITION
09/25/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/21/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/05/2018
ALIE
ASSIGNED TO LIE
08/20/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2018
GNRT
NON-FINAL ACTION E-MAILED
04/03/2018
CNRT
NON-FINAL ACTION WRITTEN
04/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2018
RFNT
REFUSAL PROCESSED BY IB
09/29/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2017
RFRR
REFUSAL PROCESSED BY MPU
09/11/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/06/2017
CNRT
NON-FINAL ACTION WRITTEN
09/05/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/29/2017
DOCK
ASSIGNED TO EXAMINER
08/25/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/24/2017
Continuous trademark protection
Get notified about every new filing that threatens ID-NET ABC 123 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.